• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP

5 Pa­tient En­gage­ment & Re­cruit­ment Trends, and How to Keep Up with Them

Yesterday

Da­ta Qual­i­ty 2.0: The Fu­ture of Re­al-World Ev­i­dence

Yesterday

Ad­vanc­ing Sleep Med­i­cine: Pi­o­neer­ing Re­search and Car­dio­vas­cu­lar Health in Nar­colep­sy

Last week

In­no­va­tion and growth: key in­gre­di­ents for health­care M&A

3 weeks ago

How Clover­tex blends be­spoke and off-the-rack cloud com­put­ing in Phar­ma

3 weeks ago

The RIGHT pro­tein and the case for cryo-EM with Pro­teros

5 weeks ago

PRO­TAC® Pro­tein De­graders: How Arv­inas is Pi­o­neer­ing Po­ten­tial Next-Gen­er­a­tion Treat­ments for Neu­rode­gen­er­a­tive Dis­eases

Last month

A Look In­side the Bou­tique En­roll­ment Agency Spon­sors Are Clam­or­ing to Work With

Last month

How to Ac­cel­er­ate De­vel­op­ment in Nov­el & Ad­vanced On­col­o­gy Ther­a­pies - From the Start­ing Line

Last month

Save Time and Up to 43.5% on Clin­i­cal Tri­al Spend Con­duct­ing Aus­tralian and US Tri­als

2 months ago

Im­muno-On­col­o­gy 2.0: How Re­gen­eron is Uti­liz­ing its Ex­per­tise in An­ti­bod­ies to Lead the Next Wave of Com­bi­na­to­r­i­al Ap­proach­es in Can­cer Care

2 months ago

No Good Drug Left Be­hind: Sen­si­tiv­i­ty and Speci­fici­ty in Drug De­vel­op­ment Ex­plained

3 months ago

The Path to Pro­duc­tiv­i­ty: Tack­ling the Cri­sis in Drug De­vel­op­ment us­ing Im­proved Pre­clin­i­cal Mod­els

3 months ago

Am­pli­fy the Pa­tient Voice in Clin­i­cal Re­search Tech­nol­o­gy De­vel­op­ment

3 months ago

The new rules of can­cer care: Re­spond­ing to in­creas­ing CMS in­flu­ence on the on­col­o­gy land­scape

3 months ago

Pro­tect­ing the glob­al phar­ma­ceu­ti­cal in­no­va­tion ecosys­tem – what’s at stake?

4 months ago

Achiev­ing Dig­i­tal Trans­for­ma­tion: Un­lock­ing Cost Re­duc­tion, Clin­i­cal Ex­cel­lence & Pre­ci­sion Ther­a­peu­tics Man­u­fac­tur­ing

4 months ago

Gene Edit­ing Tech­nol­o­gy’s $50 Bil­lion Mar­ket Op­por­tu­ni­ty

4 months ago

How In­smed is Pi­o­neer­ing the Next Fron­tier in Rare Dis­ease R&D

4 months ago

Fortress Bio’s Unique Busi­ness Mod­el Ide­al­ly Suit­ed to Thrive in Biotech’s Bear Mar­ket

4 months ago

Why this bou­tique biotech agency is the fu­ture of clin­i­cal re­cruit­ment

5 months ago

The Fu­ture of Vac­cine Re­search: the Evolv­ing Glob­al Land­scape

5 months ago

Has the mo­ment fi­nal­ly ar­rived for val­ue-based health­care?

5 months ago

Forge Bi­o­log­ics’ cGMP Com­pli­ant and Com­mer­cial­ly Vi­able Be­spoke Affin­i­ty Chro­matog­ra­phy Plat­form

6 months ago
1234 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2023

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times
Endpoints News

Log in to your account

email

password

Endpoints News

request magic link

If you're already an Endpoints subscriber, enter your email below for a magic link that lets you log in quickly without using a password. Please note the magic link is one-time use only and expires after 24 hours.

email

Endpoints News

reset password

We'll e-mail you a link to set a new password. Please note this link is one-time use only and is valid for only 24 hours.

email

Endpoints News

Sign up for free to read a limited number of articles each month.

About You

Newsletter Interests

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 2 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS MARKETING RX Tue at 2 PM ET

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

Healthcare

ENDPOINTS HEALTH TECH Coming soon

Want unlimited access? Sign up for a premium subscription plan.

Endpoints News

Confirm Profile

Endpoints News

Join over 182,300 biopharma colleagues who rely on Endpoints News every business day for the latest developments in drug discovery, development, and commercialization.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 2 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS MARKETING RX Tuesday at 2 PM ET

ENDPOINTS FDA+ Wednesday at 2 PM ET

ENDPOINTS MANUFACTURING Thursday at 2 PM ET

ENDPOINTS WEEKLY Saturday at 6 AM ET

Healthcare

ENDPOINTS HEALTH TECH Coming soon

Endpoints News